Director
Avg Cost/Share
$80.86
Shares
667
Total Value
$53,933.62
Owned After
22,667
SEC Form 4
EVP and Group CEO-VZ Business
Avg Cost/Share
$43.81
Shares
10,000
Total Value
$438,101.50
Owned After
8
EVP and Group CEO-VZ Business
Avg Cost/Share
$44.10
Shares
9,000
Total Value
$396,900.00
Owned After
8
SEC Form 4
EVP and Group CEO-VZ Business
Avg Cost/Share
$43.88
Shares
7,500
Total Value
$329,062.50
Owned After
8
SEC Form 4
EVP and Group CEO-VZ Business
Avg Cost/Share
$43.02
Shares
10,000
Total Value
$430,240.00
Owned After
8
SEC Form 4
EVP and Group CEO-VZ Business
Avg Cost/Share
$42.49
Shares
5,000
Total Value
$212,425.00
Owned After
8
SEC Form 4
EVP and Group CEO-VZ Business
Avg Cost/Share
$39.70
Shares
6,590
Total Value
$261,623.00
Owned After
8
SEC Form 4
EVP and Group CEO-VZ Business
Avg Cost/Share
$39.89
Shares
8,000
Total Value
$319,080.00
Owned After
8
SEC Form 4
EVP and Group CEO-VZ Business
Avg Cost/Share
$40.88
Shares
11,085
Total Value
$453,154.80
Owned After
8
SEC Form 4
EVP and Group CEO-VZ Business
Avg Cost/Share
$40.49
Shares
20,000
Total Value
$809,800.00
Owned After
8
SEC Form 4
EVP and Group CEO-VZ Business
Avg Cost/Share
$40.54
Shares
20,000
Total Value
$810,800.00
Owned After
8
SEC Form 4
EVP and Group CEO-VZ Business
Avg Cost/Share
$40.80
Shares
24,000
Total Value
$979,200.00
Owned After
8
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Malady Kyle | DXCM | Director | Sep 5, 2025 | Sell | $80.86 | 667 | $53,933.62 | 22,667 | |
| Malady Kyle | VZ | EVP and Group CEO-VZ Business | May 8, 2025 | Sell | $43.81 | 10,000 | $438,101.50 | 8 | |
| Malady Kyle | VZ | EVP and Group CEO-VZ Business | May 7, 2025 | Sell | $44.10 | 9,000 | $396,900.00 | 8 | |
| Malady Kyle | VZ | EVP and Group CEO-VZ Business | Apr 30, 2025 | Sell | $43.88 | 7,500 | $329,062.50 | 8 | |
| Malady Kyle | VZ | EVP and Group CEO-VZ Business | Apr 24, 2025 | Sell | $43.02 | 10,000 | $430,240.00 | 8 | |
| Malady Kyle | VZ | EVP and Group CEO-VZ Business | Apr 23, 2025 | Sell | $42.49 | 5,000 | $212,425.00 | 8 | |
| Malady Kyle | VZ | EVP and Group CEO-VZ Business | Feb 4, 2025 | Sell | $39.70 | 6,590 | $261,623.00 | 8 | |
| Malady Kyle | VZ | EVP and Group CEO-VZ Business | Feb 3, 2025 | Sell | $39.89 | 8,000 | $319,080.00 | 8 | |
| Malady Kyle | VZ | EVP and Group CEO-VZ Business | Jan 29, 2025 | Sell | $40.88 | 11,085 | $453,154.80 | 8 | |
| Malady Kyle | VZ | EVP and Group CEO-VZ Business | Jan 28, 2025 | Sell | $40.49 | 20,000 | $809,800.00 | 8 | |
| Malady Kyle | VZ | EVP and Group CEO-VZ Business | Jan 27, 2025 | Sell | $40.54 | 20,000 | $810,800.00 | 8 | |
| Malady Kyle | VZ | EVP and Group CEO-VZ Business | Feb 22, 2024 | Sell | $40.80 | 24,000 | $979,200.00 | 8 |